Literature DB >> 2318983

A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus.

I Khalil1, L d'Auriol, M Gobet, L Morin, V Lepage, I Deschamps, M S Park, L Degos, F Galibert, J Hors.   

Abstract

Family and population studies indicate that predisposition to insulin-dependent (type I) diabetes mellitus (IDDM) is polygenic. It has been shown that the absence of the aspartic acid in position 57 (Asp57) of the DQ beta chain is positively correlated to IDDM. However, Asp57-negative haplotypes do not always confer susceptibility and conversely, some Asp57-positive haplotypes seem to be disease associated. It has been suggested that other HLA class II sequences, probably belonging to the HLA DQA1 gene, confer susceptibility to IDDM. This report, based on extensive oligonucleotide dot blot hybridization of PCR-amplified DQA1 and DQB1 genes, reinforces the importance of the Asp57-negative DQ beta chain, but also introduces the possibility that a DQ alpha chain bearing an arginine in position 52 (Arg52) confers susceptibility to IDDM. A molecular model of susceptibility to IDDM is proposed. This model strongly suggests that the disease susceptibility correlates quantitatively with the expression at the cell surface of a heterodimer, composed of a DQ alpha-chain bearing an Arg52 and a DQ beta chain lacking an Asp57. In view of the respective positions of the two residues and their charge, we might anticipate that both residues DQ beta Asp57 and DQ alpha Arg52 are critical for modulation of susceptibility, presumably via viral-antigenic peptide and/or autoantigen presentation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318983      PMCID: PMC296568          DOI: 10.1172/JCI114569

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes.

Authors:  J Böhme; B Carlsson; J Wallin; E Möller; B Persson; P A Peterson; L Rask
Journal:  J Immunol       Date:  1986-08-01       Impact factor: 5.422

2.  A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules.

Authors:  J H Brown; T Jardetzky; M A Saper; B Samraoui; P J Bjorkman; D C Wiley
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

3.  Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes.

Authors:  R K Saiki; T L Bugawan; G T Horn; K B Mullis; H A Erlich
Journal:  Nature       Date:  1986 Nov 13-19       Impact factor: 49.962

4.  Sequence polymorphism of HLA DR beta 1 alleles relating to T-cell-recognized determinants.

Authors:  J S Cairns; J M Curtsinger; C A Dahl; S Freeman; B J Alter; F H Bach
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

5.  Oligonucleotide probes for HLA-DQA and DQB genes define susceptibility to type 1 (insulin-dependent) diabetes mellitus.

Authors:  D Owerbach; S Gunn; G Ty; L Wible; K H Gabbay
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

6.  Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ.

Authors:  B Michelsen; A Lernmark
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

7.  Transcomplementation of HLA genes in IDDM. HLA-DQ alpha- and beta-chains produce hybrid molecules in DR3/4 heterozygotes.

Authors:  B S Nepom; D Schwarz; J P Palmer; G T Nepom
Journal:  Diabetes       Date:  1987-01       Impact factor: 9.461

8.  The genetic susceptibility to type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association.

Authors:  E Wolf; K M Spencer; A G Cudworth
Journal:  Diabetologia       Date:  1983-04       Impact factor: 10.122

9.  Hybrid HLA-DC antigens provide molecular evidence for gene trans-complementation.

Authors:  D J Charron; V Lotteau; P Turmel
Journal:  Nature       Date:  1984 Nov 8-14       Impact factor: 49.962

Review 10.  Genetic complexity and expression of human class II histocompatibility antigens.

Authors:  A J Korman; J M Boss; T Spies; R Sorrentino; K Okada; J L Strominger
Journal:  Immunol Rev       Date:  1985-07       Impact factor: 10.983

View more
  73 in total

1.  Investigation of the mode of inheritance of insulin-dependent diabetes mellitus in Japanese subjects.

Authors:  D Jenkins; M A Penny; Y Uchigata; K H Jacobs; C H Mijovic; Y Hirata; T Otani; J Fletcher; A R Bradwell; A H Barnett
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

Review 2.  Molecular mechanisms involved in the etiology and pathogenesis of autoimmune diseases.

Authors:  M Trucco
Journal:  Clin Investig       Date:  1992-09

Review 3.  Genetic susceptibility in type 1 diabetes and its associated autoimmune disorders.

Authors:  Akane Ide; George S Eisenbarth
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

4.  Specific HLA-DRB and -DQB alleles and haplotypes confer disease susceptibility or resistance in Bahraini type 1 diabetes patients.

Authors:  Einas M Al-Harbi; Abdul-Jabbar Abbassi; Hala Tamim; Fayza al-Jenaidi; Mariam Kooheji; Madeeha Kamal; Salwa al-Mahroos; Faisal al-Nasir; Ayesha A Motala; Wassim Y Almawi
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

Review 5.  What future for therapeutic prevention of type 1 (insulin-dependent) diabetes mellitus?

Authors:  P Pozzilli; A Signore; D Andreani
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

Review 6.  HLA 1990.

Authors:  W R Mayr
Journal:  Blut       Date:  1990-10

7.  Escaping insulin dependent diabetes.

Authors:  R D Leslie; D A Pyke
Journal:  BMJ       Date:  1991-05-11

8.  In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.

Authors:  K A Metcalfe; G A Hitman; M J Fennessy; M I McCarthy; J Tuomilehto; E Tuomilehto-Wolf
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

9.  Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice.

Authors:  L Wen; F S Wong; L Burkly; M Altieri; C Mamalaki; D Kioussis; R A Flavell; R S Sherwin
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

10.  L cells expressing DQ molecules of the DR3 and DR4 haplotypes: reactivity patterns with mAbs.

Authors:  D S Monos; E Czanky; S J Ono; S F Radka; D Kappes; J L Strominger
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.